CHRM3 and M3 muscarinic receptors are commonly over-expressed in colon cancer [3] and genetic ablation of Chrm3 or pharmacological inhibition of M3R activation in murine models of colon cancer attenuates tumor formation [5]. Here, CHRM3 is linked to malignant colon neoplasm.